Post Reply
501-520 of 1767
Just tested throwing some lots at 70.5, ang mo house (CS) buying.. :):):) i am queueing back at 0.7 and 0.705 to buy more back...
14TH MAY 2021
1. As of 14 May 2021, 12pm, the Ministry of Health (MOH) has preliminarily confirmed 24 new cases of locally transmitted COVID-19 infection, of whom 20 are linked to previous cases [1]. Amongst them, 16 had already been placed on quarantine earlier. Based on our investigations so far, the cases are in the community, and there are no new cases in the dormitories.
2. In addition, there are 28 imported cases, who had already been placed on Stay-Home Notice upon arrival in Singapore. Of these, 19 are returning Singaporeans or Singapore Permanent Residents.
3. In total, there are 52 new cases of COVID-19 infection in Singapore today.
1. As of 14 May 2021, 12pm, the Ministry of Health (MOH) has preliminarily confirmed 24 new cases of locally transmitted COVID-19 infection, of whom 20 are linked to previous cases [1]. Amongst them, 16 had already been placed on quarantine earlier. Based on our investigations so far, the cases are in the community, and there are no new cases in the dormitories.
2. In addition, there are 28 imported cases, who had already been placed on Stay-Home Notice upon arrival in Singapore. Of these, 19 are returning Singaporeans or Singapore Permanent Residents.
3. In total, there are 52 new cases of COVID-19 infection in Singapore today.
chiong
hopefully today test 75c
Flush is over... get ready to ride up....:):) This CB is giving medical stocks a reason to be played up...
Richardlai ( Date: 14-May-2021 14:18) Posted:
|
oops good call but I went out for a long lunch before lock down ! Thanks.
trader1970 ( Date: 14-May-2021 11:25) Posted:
|
Agreed. Medical n gloves supplies will be in demand..
trader1970 ( Date: 14-May-2021 11:25) Posted:
|
STGT is SAFE HAVEN and has broke out.
Can consider to invest.
Can consider to invest.
Good job UG.....continue the run up to $0.80
If " CB" is imminent, the share will run up like a crazy horse.....hold tight...:):):)
Thanks. Will sell only a bit first.
Yes SSiong looking good too but take note.
Yes SSiong looking good too but take note.
trader1970 ( Date: 14-May-2021 10:27) Posted:
|
First stop is 73 to 74... previous resistance.. Will this be broken?....what do you think? Seng Shiong heavy vol with price gains.... Smell like another " CB" otw??.. is a matter of time it ll break 73 and 74....::):):)
Richardlai ( Date: 14-May-2021 09:58) Posted:
|
Sell into strength, dyodd.
Wow must be Hari Raya gift from Malaysia !
lailiao -
tesitng 70
Huat ah ! Hope it crosses 70 cents by next week !
Once 68 firms and hold, get ready for this to move higher up today :) OTOT... It is a counter to trade and to hold too if you want at this moment... All sky is clear for this to move up as medical Leader RS is rising too... along with medtecs.. it has to catch up.. any selldown will be absorbed:):)
zandlery ( Date: 13-May-2021 13:34) Posted:
|
There will always be traders more than investor in all stock. Investor buy n just park there and observe the situation.
Trader will trade very frequently daily..... So the nature make them this way
Trader will trade very frequently daily..... So the nature make them this way
FreedomAngelz ( Date: 12-May-2021 17:47) Posted:
|
UG Healthcare Corp Ltd
Too cheap to ignore
By CIMB 11 May 2021
a) 3QFY6/21 NP of S$34.3m (a 56-fold increase yoy) was in line, despite logistical disruptions which continued to hamper sales volume.
b) Earnings could continue on an uptrend in 4QFY21, as production capacity growth offsets a gradual decline in ASP.
c) UGHC trades at an undemanding valuation of 5.4x CY22F P/E, and backed by net cash of S$50m. Maintain Add, with a DCF-based TP of S$1.20.
3QFY21: Stronger margins offset topline weakness
UG Healthcare Corp&rsquo s (UGHC) 3QFY21 net profit of S$34.3m (+6% qoq, a 56-fold increase yoy) was in line with expectations.
9M21 net profit made up 77% of our FY21F.
Despite continued logistical disruptions and shipping delays which caused lower revenue recognition in the quarter, margins surprised on the upside.
We understand utilisation rate of UGHC&rsquo s production plans remained optimal (90-95%) during the quarter, and
the higher inventory level (c.S$70m as of end-Mar) will be progressively recognised in coming months with gradual easing of shipping delays.
Gradual tapering off in ASPs
Given the increase in global glove supply with incoming capacity from new and existing glove makers, we understand that glove prices have generally started to taper off since Mar.
UGHC&rsquo s ASPs is expected to normalise at a slower pace in 4QFY21 compared to peers, as we believe its original brand manufacturing (OBM) model allows it to have more control over pricing.
Our FY21F forecast remains intact as we had previously factored in monthly ASP declines since Apr
we continue to expect UGHC to report a stronger profit sequentially in 4Q as production capacity growth offsets the negative impact from ASP decline.
On the lookout for further capacity expansion
Capacity expansion of 500m pcs/annum came on stream since Apr 2021, and the new factory for additional 1.2bn pcs/annum capacity should be fully commissioned by end-Sep.
Post which, UGHC&rsquo s total manufacturing capacity will reach 4.6bn pcs/annum (+59% yoy).
Leveraging on the industry&rsquo s favourable demand-supply dynamics and UGHC strengthened balance sheet (net cash of S$50m as of end-3QFY21),
we see the possibility of further production capacity expansion in CY22F.
Reiterate Add with DCF-based TP of S$1.20
Maintain Add as UGHC continues to enjoy tailwinds of higher glove prices, and valuation is undemanding at 5.4x CY22F P/E, supported by net cash of S$50m.
However, in view of the inflection in selling prices, we switch to a DCF valuation methodology to better reflect earnings normalisation in coming years.
Our TP is lowered to S$1.20, implying 9.9x CY22F P/E.
Re-rating catalysts include stronger-than-expected demand for gloves downside risks include steeper glove pricing decline.
-------------------------